Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca gets a boost from durvalumab PhIII chatter as pipeline wear and tear starts to show
AstraZeneca gets a boost from durvalumab PhIII chatter as pipeline wear and tear starts to show
AstraZeneca gets a boost from durvalumab PhIII chatter as pipeline wear and tear starts to show
Submitted by
admin
on August 12, 2016 - 9:52am
Source:
Endpoints
News Tags:
AstraZeneca
durvalumab
lung cancer
Headline:
AstraZeneca gets a boost from durvalumab PhIII chatter as pipeline wear and tear starts to show
Do Not Allow Advertisers to Use My Personal information
